The IL-17B/RB pathway has been shown to enhance the expression of chemokines CCL20, CXCL1, IL-8, and TFF1 by regulating the ERK1/2 pathway [33], thereby promoting metastasis and malignancy in pancreatic cancer (Figure 2C). Here, IL17B is linked to pancreatic neoplasm.